| #51 |
Ian Dunckley |
British American Tobacco |
3 |
| #51 |
Trevor Baglin |
Johnson & Johnson |
3 |
| #51 |
Florian Hollfelder |
Medical Research Council |
3 |
| #51 |
Miles William Noel Hember |
Bedford Systems |
3 |
| #51 |
Christopher William Murray |
Astex Therapeutics Limited |
3 |
| #51 |
Peter Richard Greenhalgh |
NVIDIA |
3 |
| #51 |
Barnaby Balmforth |
Base4 Innovation |
3 |
| #51 |
Mark Francis Lucien Harper |
Bp Corporation North America |
3 |
| #51 |
Sahan S. Gamage |
Intel |
3 |
| #51 |
Edward Walker |
Bicyclerd Limited |
3 |
| #51 |
Jethro Bennett |
— |
3 |
| #51 |
Richard Roy Grisenthwaite |
NVIDIA |
3 |
| #51 |
Paul Graham Wilkins |
Bedford Systems |
3 |
| #51 |
Marnie Duncan |
Gw Pharma |
3 |
| #51 |
Gilles Charbit |
Nokia |
3 |
| #51 |
Bozidar Radunovic |
Microsoft |
3 |
| #51 |
Wai Ting Chan |
Bedford Systems |
3 |
| #51 |
Ian Charles Blair |
Qualcomm |
3 |
| #51 |
Emilie Jolibois |
Intercept Pharmaceuticals |
3 |
| #51 |
Catherine Stace |
Bicyclerd Limited |
3 |
| #51 |
Philip Bland-Ward |
Kymab Limited |
3 |
| #51 |
Enrico Mastrobattista |
Medical Research Council |
3 |
| #51 |
Cecilia J. Aas |
IBM |
3 |
| #51 |
Everhard Johan Muijzert |
Westerngeco L.L.C. |
3 |
| #51 |
Tobias William Barr Ost |
Illumina Cambridge Limited |
3 |
| #51 |
Guy Larri |
NVIDIA |
3 |
| #51 |
James Stewart Scott |
Astrazeneca Ab |
3 |
| #51 |
Simon Francis Brereton |
Sanofi-Aventis |
3 |
| #51 |
Stefano Borini |
Nokia Technologies Oy |
3 |
| #51 |
Jamie Campbell |
Kymab Limited |
3 |
| #51 |
Daniel Hillebrand O'Donovan |
Astrazeneca Ab |
3 |
| #51 |
Thomas James McPherson |
Castrol Limited |
3 |
| #51 |
Rafal Mantiuk |
Max-Planck-Gesellschaft Zur Föderung Der Wissenschaften E.V. |
3 |
| #51 |
Matthew David Waterson |
Power Integrations |
3 |
| #51 |
Miha Kosmac |
Kymab Limited |
3 |
| #51 |
Yuval Elad |
NVIDIA |
3 |
| #51 |
Bernd Matthias Frohlich |
Kabushiki Kaisha Toshiba |
3 |
| #51 |
Andreas Hansson |
NVIDIA |
3 |
| #51 |
Malcolm Walden |
Euro-Celtique S.A. |
3 |
| #51 |
Roberto Cipolla |
Kabushiki Kaisha Toshiba |
3 |
| #51 |
Thomas Andrew Moss |
Astrazeneca Ab |
3 |
| #51 |
Gianluca Camuso |
— |
3 |
| #51 |
Scott Grubb |
Bedford Systems |
3 |
| #51 |
David Sweeney |
Microsoft |
3 |
| #51 |
Nigel Dickens |
Adder Technology Limited |
3 |
| #51 |
Cameron Alexander FRAYLING |
Base4 Innovation |
3 |
| #51 |
Otmar Hilliges |
Microsoft |
3 |
| #51 |
Michael Alistair O'Brien |
Astex Therapeutics Limited |
3 |
| #51 |
David Michael Bull |
NVIDIA |
3 |
| #51 |
Ian Kirby |
Kymab Limited |
3 |